Allergan fell $1.91 or 1.7 percent, to $112.51. Baxter International Inc. fell$. 62 or. 9 percent, to $70.50. Boston Scientific Corp. fell$. 06 or. 8 percent, to $7.86.
CAMBRIDGE, Mass.-- InVivo Therapeutics Holdings Corp. said Friday that the Food and Drug Administration will allow it to start human trials of an experimental product that is intended to treat spinal cord injuries. The Cambridge, Mass., company said there are no FDA- approved treatments that intervene directly in the spinal cord following an injury.
Allergan fell $1.69 or 1.5 percent, to $112.73. Baxter International Inc. fell$. 67 or. 9 percent, to $70.45. Boston Scientific Corp. fell$. 07 or. 8 percent, to $7.86.
Allergan fell $1.34 or 1.2 percent, to $113.08. Baxter International Inc. fell$. 54 or. 8 percent, to $70.59. Boston Scientific Corp. fell$. 11 or 1.4 percent, to $7.81.
Allergan rose$. 57 or. 5 percent, to $114.42. Baxter International Inc. fell$. 24 or. 3 percent, to $71.12. Johnson& Johnson rose$. 34 or. 4 percent, to $82.41.
Allergan fell$. 03 or percent, to $113.82. Baxter International Inc. fell$. 23 or. 3 percent, to $71.13. Boston Scientific Corp. rose$. 06 or. 8 percent, to $7.81.
Allergan rose$. 63 or. 6 percent, to $114.48. Baxter International Inc. rose$. 72 or 1.0 percent, to $72.08. Boston Scientific Corp. rose$. 04 or. 5 percent, to $7.79.
NEW YORK-- Shares of Navidea Biopharmaceuticals Inc. rose Thursday after the company reported favorable new clinical trial results for its imaging agent Lymphoseek. The Food and Drug Administration approved Lymphoseek March 13 to help doctors locate lymph nodes in patients with breast cancer and skin cancer.
Allergan fell$. 94 or. 8 percent, to $113.85. Baxter International Inc. fell$. 85 or 1.2 percent, to $71.36. Boston Scientific Corp. fell$. 14 or 1.8 percent, to $7.75.
Allergan fell$. 93 or. 8 percent, to $113.86. Baxter International Inc. fell$. 57 or. 8 percent, to $71.64. Boston Scientific Corp. fell$. 13 or 1.6 percent, to $7.77.
Allergan fell$. 35 or. 3 percent, to $114.44. Baxter International Inc. fell$. 23 or. 3 percent, to $71.98. Johnson& Johnson fell$. 57 or. 7 percent, to $82.12.
Allergan rose $2.21 or 2.0 percent, to $114.79. Baxter International Inc. fell$. 09 or. 1 percent, to $72.21. Boston Scientific Corp. rose$. 09 or 1.2 percent, to $7.89.
MINNEAPOLIS-- Medical device maker Medtronic Inc. said Tuesday it received U.S. clearance for a new artificial lung system for patients who are undergoing open heart surgery. Each year about 1 million patients worldwide undergo cardiopulmonary bypass surgery, a procedure in which the heart and lungs are temporarily stopped, according to Medtronic.
Allergan rose $2.13 or 1.9 percent, to $114.71. Boston Scientific rose$. 14 or 1.8 percent, to $7.94. Johnson& Johnson rose$. 43 or. 5 percent, to $82.36.
MINNEAPOLIS-- Medical device maker Medtronic Inc. said Tuesday it received U.S. clearance for a new artificial lung system that breathes for patients who are undergoing open heart surgery.
Allergan rose $1.10 or 1.0 percent, to $113.68. Baxter International Inc. rose$. 15 or. 2 percent, to $72.45. Boston Scientific Corp. rose$. 09 or 1.2 percent, to $7.89.
Allergan rose$. 95 or. 9 percent, to $112.58. Baxter International Inc. fell$. 34 or. 5 percent, to $72.30. Boston Scientific Corp. fell$. 01 or. 1 percent, to $7.80.
Allergan rose$. 41 or. 4 percent, to $112.04. Baxter International Inc. fell$. 25 or. 3 percent, to $72.39. Boston Scientific Corp. fell$. 04 or. 5 percent, to $7.77.
Allergan fell$. 21 or. 2 percent, to $111.42. Baxter International Inc. fell$. 03 or percent, to $72.61. Boston Scientific Corp. fell$. 01 or. 1 percent, to $7.80.
Baxter International Inc. rose$. 76 or 1.1 percent, to $72.64. Boston Scientific Corp. rose$. 16 or 2.1 percent, to $7.81. Johnson& Johnson rose$. 26 or. 3 percent, to $81.53.